Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:00 AM UTC
| NCT Number | NCT06234423 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 263 participants |
| Active Locations | 14 sites in the US |
| Sponsor | OnCusp Therapeutics, Inc. |
| Last Updated on CT.gov | January 14, 2026 (Jan 14, 2026) |
As of July 13, 2026: Clinical trial NCT06234423 is currently recruiting participants. This clinical trial study for ovarian cancer is actively seeking new participants at 14 locations across the United States. The study is sponsored by OnCusp Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06234423 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06234423 was last updated Jan 14, 2026 (January 14, 2026). HelloStudys verifies this status automatically.